불프로그 AI 홀딩스(BFRG)는 NASDAQ에 상장된 Healthcare · Health Information Services 기업입니다. 현재가 $0.57 (-3.86%), 시가총액 $0.02B, 52주 범위 $0.46 ~ $2.10.
Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole , which is in the first phase for the treatment of Glioblastoma; BF-223, a novel prodrug of mebendazole, which is in the preclinical stage for the treatment of Glioblastoma; and BF-114, which is in the discovery phase, to treat obesity and chronic
불프로그 AI 홀딩스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.
불프로그 AI 홀딩스의 현재 주가는 $0.57 (-3.86%)입니다. BlackQuant에서 실시간 시세와 차트를 확인할 수 있습니다.
불프로그 AI 홀딩스의 시가총액은 약 $0.02B입니다.
Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare